Marshall Wace North America’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$99.9M Buy
831,635
+75,654
+10% +$8.81M 0.43% 46
2021
Q2
$90.6M Sell
755,981
-115,324
-13% -$12.7M 0.38% 55
2021
Q1
$86.6M Buy
871,305
+638,429
+274% +$64.2M 0.36% 59
2020
Q4
$23.3M Buy
+232,876
New +$24.7M 0.11% 220
2020
Q3
Sell
-144,057
Closed -$15.2M 1204
2020
Q2
$15.2M Buy
144,057
+85,718
+147% +$8.85M 0.1% 212
2020
Q1
$5.21M Sell
58,339
-1,012,344
-95% -$95.3M 0.04% 314
2019
Q4
$107M Sell
1,070,683
-635,155
-37% -$59.8M 0.52% 50
2019
Q3
$152M Buy
1,705,838
+199,013
+13% +$17.3M 0.86% 27
2019
Q2
$124M Buy
1,506,825
+1,449,499
+2,529% +$114M 0.77% 31
2019
Q1
$4.64M Buy
+57,326
New +$4.52M 0.03% 338
2018
Q3
Sell
-42,702
Closed -$3M 927
2018
Q2
$3M Buy
+42,702
New +$3.07M 0.02% 655
2017
Q4
Sell
-17,988
Closed -$1.22M 1368
2017
Q3
$1.22M Sell
17,988
-143,876
-89% -$9.09M 0.01% 908
2017
Q2
$11M Buy
+161,864
New +$10.6M 0.08% 297
2013
Q4
Sell
-6,347
Closed -$330K 695
2013
Q3
$330K Sell
6,347
-77,431
-92% -$3.89M 0.01% 502
2013
Q2
$3.96M Buy
+83,778
New +$4.27M 0.31% 111

Other funds holding AZN